Your browser doesn't support javascript.
loading
Optogenetic Control of the BMP Signaling Pathway.
Humphreys, Paul A; Woods, Steven; Smith, Christopher A; Bates, Nicola; Cain, Stuart A; Lucas, Robert; Kimber, Susan J.
Afiliação
  • Humphreys PA; Division of Cell Matrix & Regenerative Medicine, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, M13 9PL, U.K.
  • Woods S; Division of Neuroscience & Experimental Psychology, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, M13 9PL, U.K.
  • Smith CA; Division of Cell Matrix & Regenerative Medicine, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, M13 9PL, U.K.
  • Bates N; Division of Cell Matrix & Regenerative Medicine, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, M13 9PL, U.K.
  • Cain SA; Division of Cell Matrix & Regenerative Medicine, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, M13 9PL, U.K.
  • Lucas R; Division of Cell Matrix & Regenerative Medicine, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, M13 9PL, U.K.
  • Kimber SJ; Division of Neuroscience & Experimental Psychology, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, M13 9PL, U.K.
ACS Synth Biol ; 9(11): 3067-3078, 2020 11 20.
Article em En | MEDLINE | ID: mdl-33084303
Bone morphogenetic proteins (BMPs) are members of the transforming growth factor ß (TGFß) superfamily and have crucial roles during development; including mesodermal patterning and specification of renal, hepatic, and skeletal tissues. In vitro developmental models currently rely upon costly and unreliable recombinant BMP proteins that do not enable dynamic or precise activation of the BMP signaling pathway. Here, we report the development of an optogenetic BMP signaling system (optoBMP) that enables rapid induction of the canonical BMP signaling pathway driven by illumination with blue light. We demonstrate the utility of the optoBMP system in multiple human cell lines to initiate signal transduction through phosphorylation and nuclear translocation of SMAD1/5, leading to upregulation of BMP target genes including Inhibitors of DNA binding ID2 and ID4. Furthermore, we demonstrate how the optoBMP system can be used to fine-tune activation of the BMP signaling pathway through variable light stimulation. Optogenetic control of BMP signaling will enable dynamic and high-throughput intervention across a variety of applications in cellular and developmental systems.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transdução de Sinais / Proteínas Morfogenéticas Ósseas Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transdução de Sinais / Proteínas Morfogenéticas Ósseas Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article